Trinidad and Tobago Securities and Exchange Commission

CVD Equipment Corporation to Announce Third Quarter 2023 Financial Results on November 14, 2023

Retrieved on: 
화요일, 11월 7, 2023

CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition and thermal process equipment, announced today that it will release its third quarter 2023 financial results after the markets close on Tuesday, November 14, 2023.

Key Points: 
  • CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition and thermal process equipment, announced today that it will release its third quarter 2023 financial results after the markets close on Tuesday, November 14, 2023.
  • The Company will hold a conference call to discuss its results at 5:00 p.m. (Eastern Time) that day.
  • To participate in the live conference call, please dial toll free (877) 407-2991 or international (201) 389-0925.
  • Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties.

Tempo Automation Holdings, Inc. Announces Commencement of Nasdaq Delisting Proceedings

Retrieved on: 
금요일, 10월 27, 2023

SAN FRANCISCO, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Tempo Automation Holdings, Inc. (NASDAQ: TMPO) (the “Company”) announced today that on October 24, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”).

Key Points: 
  • SAN FRANCISCO, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Tempo Automation Holdings, Inc. (NASDAQ: TMPO) (the “Company”) announced today that on October 24, 2023, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”).
  • As a result, the Company was required to submit its plan to regain compliance with the Delinquency Rule by October 26, 2023.
  • In its October 24 letter, Nasdaq notified the Company that, pursuant to Listing Rule 5810(d)(2), these deficiencies serve as additional and separate bases for delisting, and as a result, the Company's securities will be delisted from The Nasdaq Global Market.
  • The Company does not intend to appeal Nasdaq's determination.

Trinseo Announces Release Date and Conference Call for its Third Quarter 2023 Financial Results

Retrieved on: 
목요일, 10월 12, 2023

After registering for the conference call, you will receive a confirmation email with a meeting invitation and information for entry.

Key Points: 
  • After registering for the conference call, you will receive a confirmation email with a meeting invitation and information for entry.
  • Trinseo will distribute its third quarter 2023 financial results via press release on Business Wire and post the release and presentation slides on the Company’s Investor Relations website on Friday, November 3, 2023 after the market close.
  • The Company will furnish copies of the financial results press release and presentation slides to investors by means of a Form 8-K filing with the U.S. Securities and Exchange Commission.
  • A replay of the conference call and transcript will be archived on the Company’s Investor Relations website shortly following the conference call.

NYSE to Commence Delisting Proceedings Against SIGNA Sports United N.V. (SSU)

Retrieved on: 
수요일, 10월 11, 2023

NYSE Regulation has determined that the Company’s Securities are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.

Key Points: 
  • NYSE Regulation has determined that the Company’s Securities are no longer suitable for listing based on “abnormally low” price levels, pursuant to Section 802.01D of the Listed Company Manual.
  • The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange.
  • The NYSE will apply to the Securities and Exchange Commission to delist the Company’s Securities upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20231011565825/en/

UL Solutions Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Retrieved on: 
월요일, 10월 2, 2023

The Issuer does not expect to receive any proceeds from the proposed offering.

Key Points: 
  • The Issuer does not expect to receive any proceeds from the proposed offering.
  • The proposed offering would constitute the Issuer’s initial public offering.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • The proposed initial public offering is subject to market and other conditions, including completion of the SEC’s review of the registration statement.

EQS-News: Abivax announces plans to conduct registered public offering in the United States

Retrieved on: 
목요일, 8월 10, 2023

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • PARIS, France, August 10, 2023 – 06:00 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) today announced that it plans to conduct a registered public offering of its ordinary shares, in the form of American Depositary Shares, in the United States, subject to market and other conditions, and has confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission.
  • The timing, number of securities to be offered in the proposed offering and their price have not yet been determined.
  • This press release does not, and is not intended to, constitute an offer to sell or the solicitation of an offer to buy securities, and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

Metals Acquisition Limited Announces Drill Results from CSA Mine Including 20.7m @ 14.4% Cu, 25.5m @ 12.7% Cu and 28.7m @ 10.6 % Cu

Retrieved on: 
월요일, 7월 31, 2023

There are very few similar grade mines available for investors to directly participate in that are also located in Tier 1 jurisdictions.

Key Points: 
  • There are very few similar grade mines available for investors to directly participate in that are also located in Tier 1 jurisdictions.
  • The mine has been out of the public domain for 24 years and these type of drill results are a testament of MAC’s rationale for acquiring the operation.
  • This has been aimed at improving confidence in the Inferred Resource and identifying additional mineralization that could be converted to a Mineral Resource.
  • Drilling has continued to demonstrate the continuity and high-grade nature of the CSA ore bodies as shown in Table 1 below.

Labrador Names Broc Romanek to Lead Corporate Disclosure Transparency Initiative

Retrieved on: 
수요일, 6월 21, 2023

Labrador , a global communications firm specializing in corporate disclosures, announced a partnership with Broc Romanek, the industry-renowned expert for corporate disclosure transparency, to help establish the first-ever independent Transparency Scientific Committee and launch the RealTransparentDisclosure.com thought leadership site.

Key Points: 
  • Labrador , a global communications firm specializing in corporate disclosures, announced a partnership with Broc Romanek, the industry-renowned expert for corporate disclosure transparency, to help establish the first-ever independent Transparency Scientific Committee and launch the RealTransparentDisclosure.com thought leadership site.
  • Both efforts strongly advocate for greater transparency in corporate disclosure, a mission shared by Romanek and Labrador, the creator and organizer of the Transparency Awards in the U.S. and Europe.
  • Labrador, the first firm to focus on creating transparent SEC and stakeholder communications, established transparency standards that have contributed to a broad improvement in corporate disclosure readability and efficacy.
  • In the U.S., Labrador demonstrates its passion for transparency through its commitment to its Transparency Awards, rewarding the quality of disclosure provided by all S&P 250 companies.

EESTech (OTC:EESH) Announces Upgrade to the OTCQB

Retrieved on: 
월요일, 5월 22, 2023

NEW CASTLE, Del., May 22, 2023 /PRNewswire/ -- EESTech (OTC: EESH) -- EESTech, a specialist in the provision of reclamation and remediation services to the world's mining and minerals processing industries, today announced its company's common stock has been approved for upgraded quotation on the OTCQB Venture Market, effective as of May 22, 2023.

Key Points: 
  • NEW CASTLE, Del., May 22, 2023 /PRNewswire/ -- EESTech (OTC: EESH) -- EESTech, a specialist in the provision of reclamation and remediation services to the world's mining and minerals processing industries, today announced its company's common stock has been approved for upgraded quotation on the OTCQB Venture Market, effective as of May 22, 2023.
  • OTCQB is a venture market operated by the OTC Markets Group Inc. To be eligible for quotation on the OTCQB, companies must be current in their reporting and undergo an annual verification and management certification process.
  • OTCQB is recognized by the U.S. Securities and Exchange Commission as an established public market and provides current public information to investors who need to analyze, value, and trade securities.
  • "We are pleased to join over 900 other companies on the OTCQB, our up-listing and inclusion in the OTCQB market will ensure greater transparency for our shareholders, customers, partners and the public," said Murray Bailey, CEO of EESTech Inc. "EESTech is privileged to be upgraded to this more established marketplace along with increased accessibility to the company's information for our shareholders and clients."

Axcella Reports First Quarter Financial Results and Provides Business Update

Retrieved on: 
목요일, 5월 4, 2023

Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced financial results for the first quarter ended March 31, 2023 and provided a business update.

Key Points: 
  • Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced financial results for the first quarter ended March 31, 2023 and provided a business update.
  • Net Loss: Net loss for the quarter ended March 31, 2023 was $4.0 million, or $0.05 per basic and diluted share.
  • This compares with a net loss of $19.0 million, or $0.46 per basic and diluted share, for the quarter ended March 31, 2022.
  • As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis.